当前位置:首页 - 行情中心 - 亚宝药业(600351) - 财务分析 - 现金流量表

亚宝药业

(600351)

  

流通市值:46.92亿  总市值:46.92亿
流通股本:6.92亿   总股本:6.92亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,079,002,931.1523,132,410.532,154,303,813.941,639,675,251.49
  收到的税费返还114,511.722,761.061,125,612.88862,526.88
  收到其他与经营活动有关的现金56,441,496.9535,081,038.69149,998,947.87115,483,977.41
  经营活动现金流入小计1,135,558,939.77558,216,210.282,305,428,374.691,756,021,755.78
  购买商品、接受劳务支付的现金229,940,070.28119,227,068.45571,710,965.99448,038,662.1
  支付给职工以及为职工支付的现金215,104,226.77106,690,181.7458,262,574.23314,652,788.51
  支付的各项税费130,541,710.0247,615,883.86244,798,026.27177,425,795.24
  支付其他与经营活动有关的现金207,111,147.1798,247,839456,891,094.17359,242,436.54
  经营活动现金流出小计782,697,154.24371,780,973.011,731,662,660.661,299,359,682.39
  经营活动产生的现金流量净额352,861,785.53186,435,237.27573,765,714.03456,662,073.39
二、投资活动产生的现金流量:
  收回投资收到的现金214,152,581.35208,239,538.34213,966,376.2144,773,736.17
  取得投资收益收到的现金285,136.55227,869.194,235,400.98666,832.96
  处置固定资产、无形资产和其他长期资产收回的现金净额3,168,7631,693,0001,002,264.2201,526.85
  处置子公司及其他营业单位收到的现金净额--53,955,854.57-
  投资活动现金流入小计217,606,480.9210,160,407.53273,159,895.95145,642,095.98
  购建固定资产、无形资产和其他长期资产支付的现金15,059,309.189,146,315.6548,851,349.2638,768,594.99
  投资支付的现金211,560,045.44207,094,946.26127,807,822.81151,449,511.06
  投资活动现金流出小计226,619,354.62216,241,261.91176,659,172.07190,218,106.05
  投资活动产生的现金流量净额-9,012,873.72-6,080,854.3896,500,723.88-44,576,010.07
三、筹资活动产生的现金流量:
  取得借款收到的现金--190,000,000190,000,000
  收到其他与筹资活动有关的现金--3,982,865.043,982,865.04
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--193,982,865.04193,982,865.04
  偿还债务支付的现金-170,625245,000,000180,000,000
  分配股利、利润或偿付利息支付的现金242,041,975.79138,400,009.2229,876,861.02225,225,627.29
  其中:子公司支付给少数股东的股利、利润--18,000,00015,300,000
  支付其他与筹资活动有关的现金2,066,650.7770,673.5147,157,836.12133,745,772.59
  筹资活动现金流出小计244,108,626.49139,341,307.7622,034,697.14538,971,399.88
  筹资活动产生的现金流量净额-244,108,626.49-139,341,307.7-428,051,832.1-344,988,534.84
四、汇率变动对现金及现金等价物的影响-50,330.18-31,527.4939,904.7852,353.07
五、现金及现金等价物净增加额99,689,955.1440,981,547.7242,254,510.5967,149,881.55
  加:期初现金及现金等价物余额820,512,511.69820,512,511.69578,258,001.1578,258,001.1
  期末现金及现金等价物余额920,202,466.83861,494,059.39820,512,511.69645,407,882.65
补充资料:
  净利润179,231,159.91-299,899,277.67-
  资产减值准备424,908.11-83,579,791.24-
  固定资产和投资性房地产折旧53,797,645.77-120,970,723.7-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧53,797,645.77-120,970,723.7-
  无形资产摊销7,143,925.75-13,089,266.6-
  长期待摊费用摊销123,762.39-567,062.93-
  处置固定资产、无形资产和其他长期资产的损失-1,530,831.53--182,987.15-
  固定资产报废损失437,807.84-278,748.15-
  公允价值变动损失16,308,139.15--19,004,345.09-
  财务费用449,024.17-1,521,821.11-
  投资损失-2,349,415.29--74,038,738.49-
  递延所得税-5,050,855.49-12,201,019.4-
  其中:递延所得税资产减少-4,972,274.61-18,025,519.33-
    递延所得税负债增加-78,580.88--5,824,499.93-
  存货的减少41,718,972.17-77,561,961.3-
  经营性应收项目的减少23,329,973.09-136,205,335.68-
  经营性应付项目的增加35,165,980.69--73,881,071.81-
  不涉及现金收支的投资和筹资活动金额其他项目3,753,528.45-1,129,560.09-
  现金的期末余额920,202,466.83-820,512,511.69-
  减:现金的期初余额820,512,511.69-578,258,001.1-
  现金及现金等价物的净增加额99,689,955.14-242,254,510.59-
公告日期2026-08-012026-04-252026-04-252025-10-25
审计意见(境内)标准无保留意见
TOP↑